Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26FNM3B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,050
Award facts
- Contract value 100% obligated
- $45,050.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $45,050.35 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract was competitively awarded without set-aside designation and features firm fixed-price pricing, with an ultimate completion date of November 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order represents a transaction under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency and military healthcare systems. The company holds an extensive portfolio of federal contract awards covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with potential awards to multiple contractors across separate regions, positioning AmerisourceBergen as a key participant in the federal military pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FNM3B?
SPE2DR26FNM3B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FNM3B worth?
The government has obligated $45,050 on SPE2DR26FNM3B.
Is contract SPE2DR26FNM3B an order under another contract?
Yes. SPE2DR26FNM3B is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNM3B competed?
The extent of competition for SPE2DR26FNM3B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award